// App-Quantinova.ai

TCT-625 : Three Year Follow up of a Randomized Comparison of Nobori, Biolimus A9 Eluting Stent(BES) with Cypher, Sirolimus Eluting Stent(SES) for Coronary Revascularization in Japanese Population

Researchers

Presenter

  • Takeshi Kimura

Principal Investigators

  • Toshiya Muramatsu

  • Masashi Iwabuchi

  • Osamu Doi

  • Shigeru Saito

  • Yasuhiko Hayashi

  • Yuji Ikari

  • Kenshi Fujii

  • Shinsuke Nanto

  • Naoto Inoue

  • Atsuo Namiki

  • Haruo Hirayama

Medical Centers

  • Sakurabashi Watanabe Hospital, Osaka, Japan

  • Cardiovascular Institute Hospital, Tokyo, Japan

  • Shizuoka Cancer Center Hospital, Shizuoka, Japan

  • Kyoto University, Kyoto, Japan

  • Kurashiki Central Hospital, Kurashiki, Japan

  • Tokai University School of Medicine, Isehara, Japan

  • Akiru Municipal Medical Center, Tokyo, Japan

  • Nagoya Daini Red Cross Hospital, Nagoya, Japan

  • Osaka University Graduate School of Medicine, Suita, Japan

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Tsuchiya General Hospital, Hiroshima, Japan

  • Kanto Rosai Hospital, Kanagawa, Japan

  • Sendai Kousei Hospital, Sendai, Japan

  • Saiseikai Yokohama-city Eastern Hospital, Yokohama, kanagawa, Japan

  • Shonan Kamakura General Hospital, Kanagawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Biolimus A9

  • Rapacan

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved